IT1101279B - Agenti terapeutici a base di derivati di ftalazina - Google Patents
Agenti terapeutici a base di derivati di ftalazinaInfo
- Publication number
- IT1101279B IT1101279B IT29369/78A IT2936978A IT1101279B IT 1101279 B IT1101279 B IT 1101279B IT 29369/78 A IT29369/78 A IT 29369/78A IT 2936978 A IT2936978 A IT 2936978A IT 1101279 B IT1101279 B IT 1101279B
- Authority
- IT
- Italy
- Prior art keywords
- therapeutic agents
- agents based
- phthalazine derivatives
- phthalazine
- derivatives
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- LFSXCDWNBUNEEM-UHFFFAOYSA-N phthalazine Chemical class C1=NN=CC2=CC=CC=C21 LFSXCDWNBUNEEM-UHFFFAOYSA-N 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
- C07D211/28—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4567077 | 1977-11-03 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IT7829369A0 IT7829369A0 (it) | 1978-11-02 |
| IT1101279B true IT1101279B (it) | 1985-09-28 |
Family
ID=10438118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT29369/78A IT1101279B (it) | 1977-11-03 | 1978-11-02 | Agenti terapeutici a base di derivati di ftalazina |
Country Status (20)
| Country | Link |
|---|---|
| JP (1) | JPS5498783A (cg-RX-API-DMAC7.html) |
| AR (3) | AR219561A1 (cg-RX-API-DMAC7.html) |
| AT (1) | AT365184B (cg-RX-API-DMAC7.html) |
| AU (1) | AU507007B2 (cg-RX-API-DMAC7.html) |
| BE (1) | BE871770A (cg-RX-API-DMAC7.html) |
| CA (1) | CA1114379A (cg-RX-API-DMAC7.html) |
| DE (1) | DE2847621A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK487978A (cg-RX-API-DMAC7.html) |
| ES (5) | ES474764A0 (cg-RX-API-DMAC7.html) |
| FI (1) | FI783326A7 (cg-RX-API-DMAC7.html) |
| FR (1) | FR2407927A1 (cg-RX-API-DMAC7.html) |
| IE (1) | IE47481B1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL55844A (cg-RX-API-DMAC7.html) |
| IT (1) | IT1101279B (cg-RX-API-DMAC7.html) |
| LU (1) | LU80458A1 (cg-RX-API-DMAC7.html) |
| NL (1) | NL7810864A (cg-RX-API-DMAC7.html) |
| PH (1) | PH14659A (cg-RX-API-DMAC7.html) |
| PT (1) | PT68734A (cg-RX-API-DMAC7.html) |
| SE (1) | SE7811322L (cg-RX-API-DMAC7.html) |
| YU (3) | YU253678A (cg-RX-API-DMAC7.html) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6215356U (cg-RX-API-DMAC7.html) * | 1985-07-15 | 1987-01-29 | ||
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| CN1784395A (zh) * | 2003-05-07 | 2006-06-07 | 埃科特莱茵药品有限公司 | 哌嗪－烷基－脲基衍生物 |
| TWI435729B (zh) | 2005-11-09 | 2014-05-01 | Combinatorx Inc | 治療病症之方法，組合物及套組 |
| MX354786B (es) | 2007-06-04 | 2018-03-21 | Synergy Pharmaceuticals Inc | Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos. |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| CA2930674A1 (en) | 2008-06-04 | 2009-12-10 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| JP2011528375A (ja) | 2008-07-16 | 2011-11-17 | シナジー ファーマシューティカルズ インコーポレイテッド | 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| KR102034748B1 (ko) | 2011-03-01 | 2019-10-21 | 시너지 파마슈티컬즈 인코포레이티드 | 구아닐레이트 사이클라제 c 작용제의 제조 방법 |
| WO2013106547A1 (en) | 2012-01-10 | 2013-07-18 | President And Fellows Of Harvard College | Beta-cell replication promoting compounds and methods of their use |
| EP3718557A3 (en) | 2013-02-25 | 2020-10-21 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonist sp-333 for use in colonic cleansing |
| CA2905435A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| US9708367B2 (en) | 2013-03-15 | 2017-07-18 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
| EP4424697A3 (en) | 2013-06-05 | 2024-12-25 | Bausch Health Ireland Limited | Ultra-pure agonists of guanylate cyclase c, method of making and using same |
| CA2920856A1 (en) | 2013-08-09 | 2015-02-12 | Ardelyx, Inc. | Ph modulating compounds for inhibiting gastrointestinal phosphate uptake |
| CN114340631A (zh) | 2019-05-21 | 2022-04-12 | 阿德利克斯股份有限公司 | 用于降低患者的血清磷酸盐的组合 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1293565A (en) * | 1969-05-03 | 1972-10-18 | Aspro Nicholas Ltd | Aminophthalazines and pharmaceutical compositions thereof |
-
1978
- 1978-10-24 CA CA314,085A patent/CA1114379A/en not_active Expired
- 1978-10-30 PH PH21752A patent/PH14659A/en unknown
- 1978-10-31 LU LU80458A patent/LU80458A1/fr unknown
- 1978-11-01 NL NL7810864A patent/NL7810864A/xx not_active Application Discontinuation
- 1978-11-01 FI FI783326A patent/FI783326A7/fi unknown
- 1978-11-01 YU YU02536/78A patent/YU253678A/xx unknown
- 1978-11-01 SE SE7811322A patent/SE7811322L/xx unknown
- 1978-11-01 DK DK487978A patent/DK487978A/da unknown
- 1978-11-01 IL IL55844A patent/IL55844A/xx unknown
- 1978-11-02 JP JP13569778A patent/JPS5498783A/ja active Granted
- 1978-11-02 DE DE19782847621 patent/DE2847621A1/de not_active Ceased
- 1978-11-02 FR FR7831063A patent/FR2407927A1/fr active Granted
- 1978-11-02 AT AT0783978A patent/AT365184B/de not_active IP Right Cessation
- 1978-11-02 PT PT68734A patent/PT68734A/pt unknown
- 1978-11-02 IE IE2166/78A patent/IE47481B1/en unknown
- 1978-11-02 IT IT29369/78A patent/IT1101279B/it active
- 1978-11-02 ES ES474764A patent/ES474764A0/es active Pending
- 1978-11-02 AU AU41276/78A patent/AU507007B2/en not_active Expired
- 1978-11-03 BE BE191543A patent/BE871770A/xx unknown
- 1978-11-10 AR AR274311A patent/AR219561A1/es active
-
1979
- 1979-04-26 ES ES479993A patent/ES479993A1/es not_active Expired
- 1979-04-26 ES ES479994A patent/ES479994A1/es not_active Expired
- 1979-04-26 ES ES479992A patent/ES479992A1/es not_active Expired
- 1979-04-26 ES ES479991A patent/ES479991A1/es not_active Expired
- 1979-11-02 AR AR278749A patent/AR217577A1/es active
- 1979-11-02 AR AR278750A patent/AR217578A1/es active
-
1982
- 1982-03-23 YU YU02115/82A patent/YU211582A/xx unknown
- 1982-09-23 YU YU02116/82A patent/YU211682A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR219561A1 (es) | 1980-08-29 |
| FI783326A7 (fi) | 1979-05-04 |
| PT68734A (en) | 1978-12-01 |
| YU211682A (en) | 1983-02-28 |
| AR217577A1 (es) | 1980-03-31 |
| AT365184B (de) | 1981-12-28 |
| AR217578A1 (es) | 1980-03-31 |
| ES474764A0 (es) | 1980-08-16 |
| YU253678A (en) | 1983-02-28 |
| ATA783978A (de) | 1981-05-15 |
| JPS5498783A (en) | 1979-08-03 |
| DE2847621A1 (de) | 1979-05-17 |
| DK487978A (da) | 1979-05-04 |
| ES479992A1 (es) | 1980-09-01 |
| JPS5538352B2 (cg-RX-API-DMAC7.html) | 1980-10-03 |
| NL7810864A (nl) | 1979-05-07 |
| YU211582A (en) | 1983-02-28 |
| ES479994A1 (es) | 1980-08-16 |
| AU507007B2 (en) | 1980-01-31 |
| CA1114379A (en) | 1981-12-15 |
| FR2407927A1 (fr) | 1979-06-01 |
| IL55844A (en) | 1982-05-31 |
| SE7811322L (sv) | 1979-05-04 |
| IT7829369A0 (it) | 1978-11-02 |
| IL55844A0 (en) | 1979-01-31 |
| ES479993A1 (es) | 1980-08-16 |
| FR2407927B1 (cg-RX-API-DMAC7.html) | 1982-07-16 |
| PH14659A (en) | 1981-10-20 |
| ES479991A1 (es) | 1980-08-16 |
| IE782166L (en) | 1979-05-03 |
| BE871770A (fr) | 1979-05-03 |
| IE47481B1 (en) | 1984-04-04 |
| LU80458A1 (fr) | 1980-05-07 |
| AU4127678A (en) | 1979-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT1094944B (it) | Derivati di ftalazina | |
| IT1160281B (it) | Tastiera perfezionata | |
| AT378901B (de) | Arbeitsstuhl | |
| FI781613A7 (fi) | Terapeutiska hydantoinfoereningar | |
| IT1105411B (it) | Derivati di ciclosano | |
| IT1098858B (it) | Derivati di immidazoli | |
| IT1098276B (it) | Derivati di trifenilalcheni | |
| DK143390C (da) | Hjulunderstel | |
| SE7808607L (sv) | Anordning for intravenos administrering | |
| IS2443A7 (is) | thekjuefni til lækninga | |
| SE7812191L (sv) | Stegstol | |
| IT1101279B (it) | Agenti terapeutici a base di derivati di ftalazina | |
| IT1100839B (it) | Composti analgesici a base di derivati di polipeptidi | |
| SE7809373L (sv) | Farmaceutiskt anvendbara 5-hydroxi-1h-imidazol-4-karboxamidderivat | |
| IT1100919B (it) | Agenti terapeutici a base di derivati di chinazolina | |
| IT1092333B (it) | Derivati di ossadiazol-pirimidine | |
| IT1111174B (it) | Derivati di piridazione | |
| IT1095493B (it) | Derivati di chinazoline | |
| IT1096166B (it) | Agenti funghicidi a base di 3-cloro-4h-1,2,6-tiadiazin-4-one mono-5-sostitutito | |
| IT1105366B (it) | Medicamento a base di derivati piridinici | |
| FR2344288A2 (fr) | Compositions therapeutiques a base de steroides | |
| IT1096294B (it) | Derivati di fenilglicina | |
| IT1098350B (it) | Derivati prostaglandinici | |
| IT1064473B (it) | Sulfamoil derivati dell'8-beta-amminometilergolina | |
| IT1096280B (it) | Cocatalizzatore a base di trialchil-alluminio |